Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

UK publishes reports comparing MR (magnetic resonance) scanners:

This article was originally published in Clinica

Executive Summary

Comparisons of magnetic resonance (MR) scanners on the UK market are highlighted in two recent reports from the medical devices section of the Medicines and Healthcare products Regulatory Agency (MHRA). The first is a comparison of 1.5 Tesla MR systems and looks at system specification and technical evaluation. This covers: the latest 1.5T systems from Siemens, GE and Philips; technical tests on parallel imaging coils and sequences; and specification data from Toshiba 1.5T MR systems. The second is a brief special interest report on the specifications of cardiac MR systems. This evaluates three systems: Siemens' Sonata Maestro Class; GE Signa Infinity (Twinspeed gradients); and Philips Intera CV. This report provides specifications on hardware, cardiac application packages, cardiac imaging sequences and parallel imaging techniques.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT063518

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel